First shipment for US CDT product to Europe
US biopharmaceutical company Scolr, latterly known as Nutraceutix, is to ship the first order for its patented controlled delivery product Glucosamine/Chondroitin to Europe.
US biopharmaceutical company Scolr, latterly known as Nutraceutix, is to ship the first order for its patented controlled delivery product Glucosamine/Chondroitin to Europe.
Two British firms, De Novo Pharmaceuticals and Peakdale Molecular, are to enter into a joint collaboration to exploit their respective skills in molecular design and chemistry synthesis, writes market analysts Datamonitor this week.
Life science company Chiral Quest this week announced that the non-profit organisation, the Penn State Research Foundation, has received a US patent covering the compositions of matter and use for a series of chiral phosphine ligands and catalysts...
UK developer of medical diagnostics devices Osmetech continued the strategy to build on its healthcare diagnostics business with the acquisition this week of the Atlanta-based 'OPTI' product line of blood gas analysers owned by Swiss healthcare...
Dutch life science company DSM reported this week that on Tuesday three people were killed following an explosion at its Melamine Plant 2 in Geleen, the Netherlands.